Association between the prognostic nutritional index (PNI) and all-cause mortality in patients with chronic kidney disease [0.03%]
预后营养指数(PNI)与慢性肾脏病患者全因死亡率之间的关系
Jian-Hong Yu,Yu Chen,Ming-Gang Yin
Jian-Hong Yu
Background: Nutrition and immunity play an important role in many chronic diseases. The prognostic nutritional index (PNI) has been proposed as a comprehensive indicator of an individual's immune and nutritional status. H...
Clinical risk factors for peritoneal dialysis withdrawal at different dialysis duration [0.03%]
不同透析时间段腹膜透析拔管的临床预测因素分析
Weizhen Xie,Li Qin,Jiaying Huang et al.
Weizhen Xie et al.
Background: The duration of patients maintained on peritoneal dialysis (PD) varied. This study investigated the clinical risk factors for PD withdrawal at different dialysis duration. ...
Serum uric acid to creatinine ratio as a risk factor for mortality among patients on continuous ambulatory peritoneal dialysis: a multi-center retrospective study [0.03%]
血液尿酸与肌酐比值与腹膜透析患者生存率的相关性分析多中心回顾性研究
Jieping Hu,Liwen Tang,Xiaojiang Zhan et al.
Jieping Hu et al.
Background: Serum uric acid to serum creatinine ratio (SUA/Scr) has emerged as a new biomarker, which is significantly associated with several metabolic diseases. However, no study has investigated the association between...
Multicenter Study
Renal failure. 2023;45(2):2273979. DOI:10.1080/0886022X.2023.2273979 2023
Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy [0.03%]
抗 PLA2R IgG 抗体导致特发性膜性肾病系膜损伤
Ying Zhang,Ping Chen,Baobao Wang et al.
Ying Zhang et al.
Background: Idiopathic membranous nephropathy is widely recognized as an autoimmune kidney disease that is accompanied by the discovery of several autoantibodies, and the antibody subclass in the circulation of patients with iMN is mainly I...
Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study [0.03%]
伊格拉替米对肾移植后矿物质和骨代谢障碍疗效的初步研究
Li Sun,Jun Tao,Zhijian Han et al.
Li Sun et al.
Background: Iguratimod has been shown to promote bone formation and inhibit bone resorption in rheumatoid arthritis patients. We aimed to explore its effect on bone metabolism and vascular calcification (VC) in kidney tra...
Collaborative peri-transplant management of volume status, hypertension, and immunosuppression: enhancing kidney transplants for better outcomes [0.03%]
围移植期肾移植受者的容量状态、高血压和免疫抑制的协作管理：改善预后的重要措施
Amy Perry,Prince Anand Mohan,Kevin Bodker et al.
Amy Perry et al.
Sex-specific time trends of long-term graft survival after kidney transplantation - a registry-based study [0.03%]
基于登记数据的肾脏移植术后长期移植物存活率的性别差异及时间变化趋势分析
Salmir Nasic,Björn Peters,Bernd Stegmayr et al.
Salmir Nasic et al.
Background: Sex-specific trends over time with respect to kidney graft survival have scarcely been described in earlier studies. The present study aimed to examine whether kidney graft survival differs between women and m...
Peer-reviewed visuals and auditory - isn't it time to incorporate? [0.03%]
同行评审的视觉和听觉内容——现在不开始整合还等何时？
Karim Soliman,Charat Thongprayoon,Wisit Cheungpasitporn
Karim Soliman
A remarkable opportunity emerges amidst the dynamic evolution of medical education, one that could fundamentally alter how healthcare professionals gain and share knowledge. The concept of incorporating a structured, peer-reviewed video and...
Research on the correlation between the renal resistive index, renal microvessel density, and fibrosis [0.03%]
肾阻力指数、肾微血管密度与肾纤维化相关性研究
Jingping Wu,Jian Liu,Guanghan Li et al.
Jingping Wu et al.
Background: This study was designed to investigate the relationship between the renal resistive index (RRI), renal microvessel density (RMD), and fibrosis in patients with chronic kidney disease (CKD). ...
The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study [0.03%]
托珠单抗在肾功能受损的新冠肺炎重症患者中的使用：一项多中心队列研究
Ohoud Aljuhani,Khalid Al Sulaiman,Ghazwa B Korayem et al.
Ohoud Aljuhani et al.
Tocilizumab (TCZ) is recommended in patients with COVID-19 who require oxygen therapy or ventilatory support. Despite the wide use of TCZ, little is known about its safety and effectiveness in patients with COVID-19 and renal impairment. Th...
Multicenter Study
Renal failure. 2023;45(2):2268213. DOI:10.1080/0886022X.2023.2268213 2023